The overexpression of these miRNAs reduces CDKN1A levels in leukemia cells, indicating that the anti-cancer activity of nitidine chloride is mediated by the c-Myc-miR-17–92 axis [91] (Figure 1 and Table 3). This evidence concerns the gene MYC and leukemia.